Ligand Pharmaceuticals Director Sells Shares Worth About $676,000
Ligand director Aryeh Jason sold 2,111 shares worth about $676,000 in transactions dated October 30 and November 2, 2026.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Ligand Pharmaceuticals director Aryeh Jason sold 2,111 common shares in trades dated October 30 and November 2, 2026, according to TradingView. The October 30 sales were executed at prices between $317.74 and $320.49 per share, while the 700 shares sold on November 2 went at a weighted-average price of $320.4261. The total proceeds came to roughly $676,158.
After the transactions, Jason directly holds 108,758 shares and indirectly holds 8,000 more. The information is based on documents filed with the SEC and was compiled with AI tools, so key figures should be checked against the original filing.
why it matters
A single director's sale of about $676,000 rarely moves a company's stock or the broader market. Filings like this are mainly watched by investors who track insider activity, but on their own they reflect one owner's decision rather than a change in the company's business outlook.
tags
instruments
sources
- Ligand Pharmaceuticals Director Sold Shares Worth Over $676K — TradingView, 4 November 2026 at 00:40 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗